Literature DB >> 20663907

Glioblastoma-specific protein interaction network identifies PP1A and CSK21 as connecting molecules between cell cycle-associated genes.

Jayashree Ladha1, Sainitin Donakonda, Shipra Agrawal, Balaram Thota, Mallavarapu R Srividya, Sambandam Sridevi, Arimappamagan Arivazhagan, Kandavel Thennarasu, Anandh Balasubramaniam, Bangalore A Chandramouli, Alangar Sattiyaranjandas Hegde, Paturu Kondaiah, Kumaravel Somasundaram, Vani Santosh, Satyanarayana M R Rao.   

Abstract

Glioblastoma (GBM; grade IV astrocytoma) is a very aggressive form of brain cancer with a poor survival and few qualified predictive markers. This study integrates experimentally validated genes that showed specific upregulation in GBM along with their protein-protein interaction information. A system level analysis was used to construct GBM-specific network. Computation of topological parameters of networks showed scale-free pattern and hierarchical organization. From the large network involving 1,447 proteins, we synthesized subnetworks and annotated them with highly enriched biological processes. A careful dissection of the functional modules, important nodes, and their connections identified two novel intermediary molecules CSK21 and protein phosphatase 1 alpha (PP1A) connecting the two subnetworks CDC2-PTEN-TOP2A-CAV1-P53 and CDC2-CAV1-RB-P53-PTEN, respectively. Real-time quantitative reverse transcription-PCR analysis revealed CSK21 to be moderately upregulated and PP1A to be overexpressed by 20-fold in GBM tumor samples. Immunohistochemical staining revealed nuclear expression of PP1A only in GBM samples. Thus, CSK21 and PP1A, whose functions are intimately associated with cell cycle regulation, might play key role in gliomagenesis. (c)2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20663907     DOI: 10.1158/0008-5472.CAN-10-0819

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

Review 1.  Targeting EGFR for treatment of glioblastoma: molecular basis to overcome resistance.

Authors:  T E Taylor; F B Furnari; W K Cavenee
Journal:  Curr Cancer Drug Targets       Date:  2012-03       Impact factor: 3.428

2.  Protein phosphatase 1 alpha enhances glucocorticoid receptor activity by a mechanism involving phosphorylation of serine-211.

Authors:  Melanie Patt; Joël Gysi; Nourdine Faresse; John A Cidlowski; Alex Odermatt
Journal:  Mol Cell Endocrinol       Date:  2020-06-22       Impact factor: 4.102

3.  Nuclear Protein Phosphatase 1 α (PP1A) Expression is Associated with Poor Prognosis in p53 Expressing Glioblastomas.

Authors:  Arun H Shastry; Balaram Thota; Mallavarapu R Srividya; Arimappamagan Arivazhagan; Vani Santosh
Journal:  Pathol Oncol Res       Date:  2015-08-09       Impact factor: 3.201

4.  Targeting protein kinase CK2 suppresses prosurvival signaling pathways and growth of glioblastoma.

Authors:  Ying Zheng; Braden C McFarland; Denis Drygin; Hao Yu; Susan L Bellis; Hyunsoo Kim; Markus Bredel; Etty N Benveniste
Journal:  Clin Cancer Res       Date:  2013-09-13       Impact factor: 12.531

5.  A travel guide to Cytoscape plugins.

Authors:  Rintaro Saito; Michael E Smoot; Keiichiro Ono; Johannes Ruscheinski; Peng-Liang Wang; Samad Lotia; Alexander R Pico; Gary D Bader; Trey Ideker
Journal:  Nat Methods       Date:  2012-11-06       Impact factor: 28.547

6.  Uncovering MicroRNA and Transcription Factor Mediated Regulatory Networks in Glioblastoma.

Authors:  Jingchun Sun; Xue Gong; Benjamin Purow; Zhongming Zhao
Journal:  PLoS Comput Biol       Date:  2012-07-19       Impact factor: 4.475

7.  Analysis of apoptosis methods recently used in Cancer Research and Cell Death & Disease publications.

Authors:  O Bucur; A L Stancu; R Khosravi-Far; A Almasan
Journal:  Cell Death Dis       Date:  2012-02-02       Impact factor: 8.469

8.  Cancer association study of aminoacyl-tRNA synthetase signaling network in glioblastoma.

Authors:  Yong-Wan Kim; Changhyuk Kwon; Juinn-Lin Liu; Se Hoon Kim; Sunghoon Kim
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

9.  Reverse engineering of modified genes by Bayesian network analysis defines molecular determinants critical to the development of glioblastoma.

Authors:  Brian W Kunkle; Changwon Yoo; Deodutta Roy
Journal:  PLoS One       Date:  2013-05-30       Impact factor: 3.240

10.  Node interference and robustness: performing virtual knock-out experiments on biological networks: the case of leukocyte integrin activation network.

Authors:  Giovanni Scardoni; Alessio Montresor; Gabriele Tosadori; Carlo Laudanna
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.